Skip to Main Content

Paper Details

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
0
2023
C3a, C5a, CD103, CD103+, CD11c, CD14, CD39, CD8, CD8+, CD8+ T cells, CXCL10, EAC, Esophageal Adenocarcinoma, GM-CSF, HLA-DRhigh, IL4, L1, L1+) monocytic myeloid-derived suppressor cells, M2-like macrophages, PD-, Treg, antitumor tissue-resident memory CD39, esophageal adenocarcinoma, immunostimulatory CD14+ CD11c+ HLA-DRhigh cells, immunosuppressive T regulatory cells, patient, patients, plasma, programmed cell death ligand 1, programmed cell death ligand 1-positive (PD, programmed cell death ligand 1-positive (PD-, putative, tumor, tumor-infiltrating CD39+ CD103+ CD8+ T cells
Author NameAffiliation
Marco PuntaCenter for OMICS Sciences, IRCCS San Raffaele Scientific Institute
Marco PuntaIRCCS San Raffaele Scientific Institute
  • 1 - 2

Datasets

Release 1.2